Cost-Effectiveness of the Second COVID-19 Booster Vaccination in the USA

ConclusionThe second booster strategy was likely to be dominant in reducing the disease burden of the COVID-19 pandemic. Expanding the second booster strategy to ages 18 –49 and 12–17 years would remain dominant due to their social contacts with the older age group.

http://link.springer.com/10.1007/s40258-023-00844-2

Source: Applied Health Economics and Health Policy - November 1, 2023 Category: Health Management Source Type: research